U.S. Prematurely Cancels Ventilator Contracts with Three Makers
(Bloomberg) -- The Trump Administration is canceling contracts for ventilators with three companies, including a $650 million deal signed in April with Royal Philips NV.
Vyaire Medical Inc. will deliver no more than 4,000 ventilators in a deal in which they contracted to provide 22,000 at a cost of $407.9 million, according to a spokesperson for the U.S. Department of Health and Human Services. Hamilton Medical will deliver no more than 4,518; the orginal agreement called for the company to provide 25,574 for $552 million.
Philips, meanwhile, said it supplied 12,300 ventilators to the U.S. Strategic National Stockpile by the end of August. However, HHS Services terminated the order for the remaining 30,700 devices without giving a reason, said Chief Executive Officer Frans van Houten.
“It's very unusual to have a contract like this canceled,” van Houten said in a phone interview. Philips nevertheless sees positive growth for the year as the company's order books are “at an all-time high,” he said.
The Strategic National Stockpile now has nearly 120,000 ventilators available, the HHS spokesperson said.
The Philips cancellation spurred the head of a U.S. House panel to say he plans to seek documentation on all contracts related to the Covid-19 pandemic by Trump administration trade adviser Peter Navarro.
The deal with Philips was “poorly negotiated,” said Raja Krishnamoorthi, a Democratic representative from Illinois who heads the Subcommittee on Economic and Consumer Policy,
Royal Philips lowered its full-year profit outlook after the U.S. government prematurely ended a $650 million contract for ventilators signed in April to combat the Covid-19 crisis.
The Dutch producer of medical equipment expects to deliver “modest comparable sales growth,” and an adjusted margin for earnings before interest, tax and amortization of around the same level as last year, it said in a statement Monday.
During the first months of the coronavirus pandemic, governments around the world scrambled to equip their health systems with ventilators to treat seriously-ill patients, with industries like the automobile sector also making the devices. Philips hired more employees, added lines and increased shifts to ensure around-the-clock manufacturing.
In April, the company based in Amsterdam said it was investing more than 100 million euros ($119 million) on increasing output of ventilators and other hospital equipment related to the virus, including by adding capacity and jobs in the U.S.
Philips, which earlier this month agreed to buy U.S. medical-device maker Intact Vascular for about $360 million, will continue to look for acquisitions in the sector to strengthen its portfolio and innovate treatment procedures, the CEO said.
©2020 Bloomberg L.P.
-
We May Need Another Tukaram Mundhe To Fight Air Pollution | The Reason Why
Developers may install basic measures such as sprinklers and green nets, resume work, and continue violating rules when this equipment stops working.
-
Extracting Value From Battery Scrap Could Be Challenging For India | The Reason Why
A discarded lithium-ion battery still contains valuable materials such as lithium, nickel and cobalt. These can be recovered and reused. When such batteries are crushed and shredded, they produce a dark powder called black mass.
-
One El Nino, India Can Handle. Two Could Break The Granary
India's grain stocks can absorb one bad year, but a second El Nino could drain the buffer in two to three years, economists say.
-
India's Troika Of Good Luck | Joining The Dots
As Jensen Huang's exit drags Nvidia down, a cooling AI trade and resilient earnings have revived investor interest in India. A likely RBI rate hike looms.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.